Pages that link to "Q41915115"

The following pages link to Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand (Q41915115):

Displaying 42 items.

• Brincidofovir (CMX001) inhibits BK polyomavirus replication in primary human urothelial cells (Q27324404) (← links)
• The Octadecyloxyethyl Ester of (S)-9-[3-Hydroxy-2-(Phosphonomethoxy) Propyl]Adenine Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication in Genotype 1A, 1B, and 2A Replicons (Q27488429) (← links)
• Solution Structure of a DNA Duplex Containing the Potent Anti-Poxvirus Agent Cidofovir (Q27666791) (← links)
• Phosphonoformic Acid Inhibits Viral Replication by Trapping the Closed Form of the DNA Polymerase (Q27667828) (← links)
• Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis (Q33632176) (← links)
• The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization (Q33782538) (← links)
• Antiproliferative effects of octadecyloxyethyl 9-[2-(phosphonomethoxy)ethyl]guanine against Me-180 human cervical cancer cells in vitro and in vivo (Q34038196) (← links)
• In vitro efficacy of brincidofovir against variola virus (Q34057540) (← links)
• Development of CMX001 for the Treatment of Poxvirus Infections (Q34801704) (← links)
• Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine (Q35013420) (← links)
• Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication (Q35116027) (← links)
• Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate. (Q35260316) (← links)
• Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B (Q35260330) (← links)
• Inhibition of HIV-1 by octadecyloxyethyl esters of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] nucleosides and evaluation of their mechanism of action (Q35364463) (← links)
• Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus. (Q36155574) (← links)
• Therapeutic and prophylactic drugs to treat orthopoxvirus infections (Q37009973) (← links)
• The 3'-to-5' exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination (Q37157260) (← links)
• Orthopoxvirus targets for the development of new antiviral agents. (Q37173398) (← links)
• Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo (Q37247639) (← links)
• Antimicrobial strategies: inhibition of viral polymerases by 3'-hydroxyl nucleosides (Q37396435) (← links)
• Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. (Q37401749) (← links)
• Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses. (Q37456244) (← links)
• Cidofovir: a novel antitumor agent for glioblastoma (Q37574749) (← links)
• The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond (Q37866422) (← links)
• Cidofovir Activity against Poxvirus Infections (Q38614278) (← links)
• Comparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studies (Q38694084) (← links)
• The vaccinia virus DNA polymerase and its processivity factor (Q39118775) (← links)
• Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus (Q39804417) (← links)
• 5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine. (Q39899952) (← links)
• Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates. (Q39929713) (← links)
• Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus (Q41343033) (← links)
• Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs (Q41361126) (← links)
• Synthesis and Anti-HIV Activity of Novel 4'-Trifluoromethylated 5'-Deoxycarbocyclic Nucleoside Phosphonic Acids (Q41504305) (← links)
• Synthesis of novel 2',3'-difluorinated 5'-deoxythreosyl phosphonic acid nucleosides as antiviral agents (Q41522072) (← links)
• Synthesis and antiviral evaluation of novel 4'-trifluoromethylated 5'-deoxyapiosyl nucleoside phosphonic acids (Q42182127) (← links)
• Vaccinia virus particles mix inefficiently, and in a way that would restrict viral recombination, in coinfected cells (Q42917842) (← links)
• Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system (Q42974816) (← links)
• Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression (Q46569170) (← links)
• Anti-DNA Virus Agents (Q56786267) (← links)
• Emerging antiviral drugs (Q56786308) (← links)
• Antivirals: current state of the art (Q56786312) (← links)
• Meeting report: 32nd International Conference on Antiviral Research (Q91852903) (← links)